DE69227897T2 - Darstellung und verwendung von butyrylcholinesterase - Google Patents

Darstellung und verwendung von butyrylcholinesterase

Info

Publication number
DE69227897T2
DE69227897T2 DE69227897T DE69227897T DE69227897T2 DE 69227897 T2 DE69227897 T2 DE 69227897T2 DE 69227897 T DE69227897 T DE 69227897T DE 69227897 T DE69227897 T DE 69227897T DE 69227897 T2 DE69227897 T2 DE 69227897T2
Authority
DE
Germany
Prior art keywords
butyrylcholinesterase
presentation
fraction
admixture
purity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227897T
Other languages
English (en)
Other versions
DE69227897D1 (de
Inventor
Thomas Lynch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Laboratories Inc
Original Assignee
Shire Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Laboratories Inc filed Critical Shire Laboratories Inc
Application granted granted Critical
Publication of DE69227897D1 publication Critical patent/DE69227897D1/de
Publication of DE69227897T2 publication Critical patent/DE69227897T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DE69227897T 1991-02-19 1992-02-19 Darstellung und verwendung von butyrylcholinesterase Expired - Fee Related DE69227897T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/657,089 US5272080A (en) 1991-02-19 1991-02-19 Production of butyrylcholinesterase
PCT/US1992/001249 WO1992014483A1 (en) 1991-02-19 1992-02-19 Production and use of butyrylcholinesterase

Publications (2)

Publication Number Publication Date
DE69227897D1 DE69227897D1 (de) 1999-01-28
DE69227897T2 true DE69227897T2 (de) 1999-05-27

Family

ID=24635769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227897T Expired - Fee Related DE69227897T2 (de) 1991-02-19 1992-02-19 Darstellung und verwendung von butyrylcholinesterase

Country Status (11)

Country Link
US (1) US5272080A (de)
EP (1) EP0575479B1 (de)
JP (1) JP3134202B2 (de)
AT (1) ATE174512T1 (de)
AU (1) AU657951B2 (de)
CA (1) CA2104381C (de)
DE (1) DE69227897T2 (de)
DK (1) DK0575479T3 (de)
ES (1) ES2125892T3 (de)
GR (1) GR3029696T3 (de)
WO (1) WO1992014483A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530839A (ja) * 2000-04-12 2003-10-21 プリンシピア ファーマスーティカル コーポレイション アルブミン融合タンパク質
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
US20070111279A1 (en) * 2002-11-13 2007-05-17 Procell, Inc. Production of recombinant therapeutic bioscavengers against chemical and biological agents
WO2007011390A2 (en) * 2004-10-09 2007-01-25 Government Of The United States As Represented By The Secretary Of The Army Large-scale production of human serum butyrylcholinesterase as a bioscavenger
WO2006063055A2 (en) * 2004-12-06 2006-06-15 Bolder Biotechnology, Inc. Enzyme conjugates for use as detoxifying agents
CA2723821C (en) * 2008-05-16 2017-05-02 Nektar Therapeutics Conjugates of a cholinesterase moiety and a polymer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63037A (en) * 1981-06-04 1985-12-31 Israel State Dioxaphosphorinanes,their preparation and pharmaceutical and veterinary compositions containing them
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
US4963345A (en) * 1988-07-18 1990-10-16 Forrest Kim K Injectable local anesthetic antidote

Also Published As

Publication number Publication date
DK0575479T3 (da) 1999-08-23
EP0575479B1 (de) 1998-12-16
EP0575479A4 (en) 1994-07-13
JP3134202B2 (ja) 2001-02-13
EP0575479A1 (de) 1993-12-29
GR3029696T3 (en) 1999-06-30
CA2104381A1 (en) 1992-08-20
CA2104381C (en) 1998-12-01
ES2125892T3 (es) 1999-03-16
AU657951B2 (en) 1995-03-30
ATE174512T1 (de) 1999-01-15
DE69227897D1 (de) 1999-01-28
AU1536692A (en) 1992-09-15
US5272080A (en) 1993-12-21
WO1992014483A1 (en) 1992-09-03
JPH06508505A (ja) 1994-09-29

Similar Documents

Publication Publication Date Title
ATE169495T1 (de) Haarshampoo
GR3008027T3 (de)
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
ATE142883T1 (de) Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren
NO951740L (no) Preparater av eikebarkekstrakt, beslektede syntetiske preparater og fremgangsmåte for anvendelse av disse
ATE174512T1 (de) Darstellung und verwendung von butyrylcholinesterase
HUT60318A (en) Compositions comprising isothiazolone derivative stabilized with phenoxyalkanol and process for producing and applying them
DE69413711D1 (de) Neue therapeutische kohlenhydratmischungen zur verwendung bei prämenstruellem syndrom
GR3006419T3 (de)
GB8902771D0 (en) Improvements in or relating to affinity chromatography
GR3004622T3 (de)
MD1714G2 (ro) Compoziţie terapeutică în formă de sirop, conţinând N-acetilcisteină
AU579909B2 (en) Improvements in and relating to ironing tables
HK27889A (en) Improvements in or relating to tables
EP0565674A4 (de)
GB2281961B (en) Improvements in or relating to the movement of members
GB9400335D0 (en) Improvements in or relating to the control of linear motors
GB9325106D0 (en) Improvements in or relating to the manufacture of similar components
ES1002074U (es) Soporte multi-giratorio para ordenadores
DE59800400D1 (de) Verwendung von freifliessendem, magnetischen Eisenoxid mit 50 bis 73 Gew.-% Eisengehalt
MY102245A (en) Purification of antibodies
BR8403051A (pt) Eliminacao de impurezas redutores em produtos organicos
ES8605314A1 (es) Perfeccionamientos en la construccion de apoyos aligerados para conducciones electricas y-o similares.
FR2566642B3 (fr) Panneau de presentation d'articles
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee